American Well Corp Files 10-K/A Amendment

TL;DR

<b>American Well Corp has filed an amendment to its 2023 annual report.</b>

AI Summary

American Well Corp (AMWL) filed a Amended Annual Report (10-K/A) with the SEC on March 1, 2024. Filing is an amendment (10-K/A) to the annual report for the period ending December 31, 2023. The company is American Well Corp, with Central Index Key 0001393584. Incorporated in Delaware, with a fiscal year end of December 31. Business and mailing address is 75 State Street, 26th Floor, Boston, MA 02109. Phone number is 617-205-3500.

Why It Matters

For investors and stakeholders tracking American Well Corp, this filing contains several important signals. This 10-K/A filing indicates potential updates or corrections to the previously filed annual report, which could contain material information for investors. The filing provides specific details about the company's structure, location, and contact information, essential for understanding its operational base.

Risk Assessment

Risk Level: low — American Well Corp shows low risk based on this filing. The filing is an amendment to a previous report, suggesting potential revisions or additions to disclosed information, but does not inherently signal new risks.

Analyst Insight

Review the specific changes made in this 10-K/A filing compared to the original 10-K to understand any updated disclosures or financial information.

Key Numbers

• 20231231 — CONFORMED PERIOD OF REPORT (Fiscal year end)
• 20240301 — FILED AS OF DATE (Date of filing)

Key Players & Entities

• American Well Corp (company) — FILER
• 0001393584 (company) — CENTRAL INDEX KEY
• DE (company) — STATE OF INCORPORATION
• Boston (company) — CITY
• MA (company) — STATE
• 02109 (company) — ZIP
• 617-205-3500 (company) — BUSINESS PHONE
• 001-39515 (company) — SEC FILE NUMBER

FAQ

Industry Context

American Well Corp operates in the healthcare technology sector, providing telehealth and virtual care solutions.

Regulatory Implications

This filing is a standard SEC disclosure under the Securities Exchange Act of 1934.

What Investors Should Do

1. Examine the specific amendments made in this 10-K/A filing.
2. Verify the accuracy of company contact and address information.
3. Note the filing date and period covered for reporting context.

Year-Over-Year Comparison

This is an amended filing (10-K/A), indicating potential revisions to the original 10-K filing for the fiscal year ended December 31, 2023.

Key Financial Figures

• $0.01 — ed Class A common stock, par value of $0.01 per share AMWL The New York Stock E
• $231.8 million — or platform subscription and visits was $231.8 million for the year ended December 31, 2023.

Filing Documents

• amwl-20231231.htm (10-K/A) — 2332KB
• amwl-ex23_1.htm (EX-23.1) — 3KB
• amwl-ex31_1.htm (EX-31.1) — 30KB
• amwl-ex31_2.htm (EX-31.2) — 15KB
• amwl-ex32_1.htm (EX-32.1) — 15KB
• amwl-ex32_2.htm (EX-32.2) — 8KB
• 0000950170-24-024026.txt (&nbsp;) — 12606KB
• amwl-20231231.xsd (EX-101.SCH) — 2002KB
• amwl-20231231_htm.xml (XML) — 2531KB

Financial Statement s and Supplementary Data

Item 8. Financial Statement s and Supplementary Data. The financial statements required to be filed pursuant to this Item 8 are appended to this Annual Report on Form 10-K, which financial statements are incorporated by reference in response to this Item 8. An index of those financial statements is found in "Item 15. Exhibits and Financial Statement Schedules" of this Annual Report on Form 10-K.

Controls and Procedures

Item 9A. Controls and Procedures. Evaluation of Disclosure Controls and Procedures Our management, with the participation of our principal executive officers and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2023. Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive officers and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officers and principal financial officer concluded that, as of December 31, 2023, our disclosure controls and procedures were effective at a reasonable assurance level. Management's Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting

Exhibits, Financ ial Statement Schedules

Item 15. Exhibits, Financ ial Statement Schedules. (1) Consolidated Financial Statements. For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K/A, incorporated into this Item by reference. (2) Consolidated Financial Statement Schedules. Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the consolidated financial statements or the notes thereto. (3) Exhibits . The exhibits listed below are filed or incorporated by reference as part of this Annual Report on Form 10-K/A. Exhibit Number Description Incorporation by Reference Form File Number Exhibit Number Filing Date 23.1* Consent of Independent Registered Public Accounting Firm 31.1* Certification of Principal Executive Officers Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 32.1* Certification of Principal Executive Officers Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 32.2* Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents 104 Cover page formatted as Inline XBRL and contained in Exhibit 101 * Filed herewith. 3 SIGNA TURES Pursuant to the requirements of Section

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements F- 8 F- 1 Report of Independent Regist ered Public Accounting Firm To the Board of Directors and Stockholders of American Well Corporation Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated balance sheets of American Well Corporation and its subsidiaries (the "Company") as of December 31, 2023 and 2022, and the related consolidated statements of operations and comprehensive loss, of stockholders' equity and of cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO. Basis for Opinions The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under

View Full Filing

View this 10-K/A filing on SEC EDGAR